Primary breast diffuse large B-cell lymphoma in the era of rituximab

BACKGROUND AND OBJECTIVE: The aim of this study was to summarize the clinical characteristics and evaluate the management approaches of primary breast diffuse large B-cell lymphoma (DLBCL) in the era of rituximab. PATIENTS AND METHODS: A total of 24 female patients with newly diagnosed primary breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Na, Cao, Caineng, Zhu, Yuan, Liu, Peng, Liu, Luying, Lu, Ke, Luo, Jialin, Zhou, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065257/
https://www.ncbi.nlm.nih.gov/pubmed/27785056
http://dx.doi.org/10.2147/OTT.S108839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065257/
https://www.ncbi.nlm.nih.gov/pubmed/27785056
http://dx.doi.org/10.2147/OTT.S108839

Ejemplares similares